Valentina Garibotto

Function: Professeure associée

Nom du groupe: Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTLab)

Group type: Main

Affiliations: Faculty of Medicine, Geneva University Hospitals, Department of Radiology and Medical Informatics

Mot clés: biomarkers, molecular neuroimaging, neurodegeneration, neurotransmission

Activités de recherche

Our research group works on molecular neuroimaging, a tool allowing the in vivo measurement of protein deposits, brain metabolism and neurotransmission. Molecular imaging has changed the way we understand brain disorders, especially those associated with neurodegeneration. In this field, the current gold standard is still neuropathology at post-mortem: this represents an intrinsic limitation for the development and assessment of targeted therapies. The availability of in vivo biomarkers of the disease, among these molecular imaging, finally offers an opportunity for precision medicine in degenerative disorders and has already changed how we evaluate patients and how we test new drugs. Our group benefits from a unique and privileged position, on one hand working in close collaboration with various research groups at the Geneva University and abroad and on the other hand being embedded in a clinical division of the Geneva University Hospitals for patient diagnosis and care. This position allows us to translate new ideas and knowledge, coming from basic and applied research programs, into procedures that can be tested in clinical studies and validated for clinical practice.

Dernières publications

Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies.

Caminiti SP , Galli A , Jonghi-Lavarini L , Boccalini C , Nicastro N , Chiti A , Garibotto V , Perani D

Parkinsonism & related disorders - Feb 2024

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

Traub-Weidinger T , Arbizu J , Barthel H , Boellaard R , Borgwardt L , Brendel M , Cecchin D , Chassoux F , Fraioli F , Garibotto V , Guedj E , Hammers A , Law I , Morbelli S , Tolboom N , Van Weehaeghe D , Verger A , Van Paesschen W , von Oertzen TJ , Zucchetta P , Semah F

European journal of nuclear medicine and molecular imaging - Feb 2024

Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.

Hönig M , Altomare D , Caprioglio C , Collij L , Barkhof F , Van Berckel B , Scheltens P , Farrar G , Battle MR , Theis H , Giehl K , Bischof GN , Garibotto V , Molinuevo JLL , Grau-Rivera O , Delrieu J , Payoux P , Demonet JF , Nordberg AK , Savitcheva I , Walker Z , Edison P , Stephens AW , Gismondi R , Jessen F , Buckley CJ , Gispert JD , Frisoni GB , Drzezga A ,

Neurology - Mar 2024

Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.

Ekmekcioglu O , Albert NL , Heinrich K , Tolboom N , Van Weehaeghe D , Traub-Weidinger T , Atay LO , Garibotto V , Morbelli S

Seminars in nuclear medicine - Feb 2024

See the complete list of the publications

Videos

Alzheimer, où en est-on ?

Contact

Département de radiologie et informatique médicale
Faculty of Medicine

Service de Médecine nucléaire et imagerie moléculaire, Département diagnostique
HUG
Email: valentina.garibotto@hcuge.ch